Similarly, elevated serum VCAM-1 levels effectively distinguished active LN from healthy controls, remission-phase LN, active non-renal SLE, and non-lupus CKD, correlating positively with proteinuria, Scr, anti-dsDNA antibodies, and negatively with complement C3. Here, VCAM1 is linked to lobular neoplasia.